These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2957362)

  • 1. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia.
    Cooper AJ
    J Clin Psychiatry; 1987 Sep; 48(9):368-70. PubMed ID: 2957362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J; Bartsch G; Jakse G
    Urol Res; 1977; 5(2):55-9. PubMed ID: 69351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J; Rachlis V; Robert E; Khait Z
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.
    Flamm J; Spona J
    Int Urol Nephrol; 1988; 20(2):131-7. PubMed ID: 2968326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.
    Hedman M; Gottlieb C; Svanborg K; Bygdeman M; de la Torre B
    Int J Androl; 1988 Aug; 11(4):265-76. PubMed ID: 2971625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
    Tomić R; Ljungberg B; Damber JE
    Scand J Urol Nephrol; 1988; 22(1):15-8. PubMed ID: 2968646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone acetate, nocturnal penile tumescence, laboratory arousal, and sexual acting out in a male with schizophrenia.
    Cooper AJ; Losztyn S; Russell NC; Cernovsky Z
    Arch Sex Behav; 1990 Aug; 19(4):361-72. PubMed ID: 2144727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia.
    Light SA; Holroyd S
    J Psychiatry Neurosci; 2006 Mar; 31(2):132-4. PubMed ID: 16575429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
    Kotarski J; Jakowicki J
    Ginekol Pol; 1985 Oct; 56(10):581-4. PubMed ID: 2936657
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ; Matthews RW; Edwards CR; Field LH; Besser GM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
    Flamm J; Spona J
    Wien Klin Wochenschr; 1987 Oct; 99(19):682-6. PubMed ID: 2961131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of sexual function in a castrated man treated with ovarian steroids.
    Davidson JM; Camargo C; Smith ER; Kwan M
    Arch Sex Behav; 1983 Jun; 12(3):263-74. PubMed ID: 6309119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate.
    Grecu EO; Weinshelbaum A; Simmons R
    Calcif Tissue Int; 1990 May; 46(5):294-9. PubMed ID: 2140069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral medroxyprogesterone acetate and methyltestosterone on sexual functioning in a male contraceptive trial.
    Doody K; Bain J
    Contraception; 1985 Jan; 31(1):65-70. PubMed ID: 3157547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate.
    Telimaa S; Apter D; Reinilä M; Rönnberg L; Kauppila A
    Eur J Obstet Gynecol Reprod Biol; 1990; 36(1-2):97-105. PubMed ID: 2142109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose oral medroxyprogesterone for inappropriate hypersexuality in elderly men with dementia: a case series.
    Cross BS; DeYoung GR; Furmaga KM
    Ann Pharmacother; 2013 Jan; 47(1):e1. PubMed ID: 23324505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.